Categories

Prolia (denosumab) by Amgen: Drug Safety Communication – FDA Investigating Risk of Severe Hypocalcemia in Patients on Dialysis

FDA is investigating the risk of severe hypocalcemia with serious outcomes, including hospitalization and death, in patients with advanced kidney disease on dialysis treated with the osteoporosis medicine Prolia (denosumab).

http://www.fda.gov/safety/medical-product-safety-information/prolia-denosumab-amgen-drug-safety-communication-fda-investigating-risk-severe-hypocalcemia-patients

 
Categories

Are you a prescriber healthcare professional 👩🏿‍⚕️👨🏽‍⚕️? Prescribe antimicrobials to your patients 💊💊 according to clinical practice guidelines in your

Are you a prescriber healthcare professional 👩🏿‍⚕️👨🏽‍⚕️?

Prescribe antimicrobials to your patients 💊💊 according to clinical practice guidelines in your country

INFO⇨ bit.ly/3Nq1mS0

#AntimicrobialResistance https://t.co/gDKEmHtN1E

 
Categories

#SkinToSkin contact enables easy manual removal of colostrum. This provides ⬇️ 🔸 defenses against infections. 🔸 promotes intestinal tolerance. 🔸

#SkinToSkin contact enables easy manual removal of colostrum.

This provides ⬇️
🔸 defenses against infections.
🔸 promotes intestinal tolerance.
🔸 enables progression to higher milk volumes and protects premature babies from serious illness.

#PrematurityAwarenessMonthhttps://t.co/QyJy4HOKGI